Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol

Jarvis Chen, John Petranka, Ken Yamamura, Robert E. London, Charles Jr Steenbergen, Elizabeth Murphy

Research output: Contribution to journalArticle

Abstract

Males exhibit enhanced myocardial ischemia-reperfusion injury versus females under hypercontractile conditions associated with increased sarcoplasmic reticulum (SR) Ca2+. We therefore examined whether there were gender differences in SR Ca2+. We used NMR Ca 2+ indicator 1,2-bis(2-amino-5,6-difluorophenoxy)-ethane-N,N,N′ ,N′-tetraacetic acid to measure SR Ca2+ in perfused rabbit hearts. Isoproterenol increased SR Ca2+ in males from a baseline of 1.13 ± 0.07 to 1.52 ± 0.24 mM (P <0.05). Female hearts had basal SR Ca2+ that was not significantly different from males (1.04 ± 0.03 mM), and addition of isoproterenol to females resulted in a time-averaged SR Ca2+ (0.97 ± 0.07 mM) that was significantly less than in males. To confirm this difference, we measured caffeine-induced release of SR Ca2+ with fura-2 in isolated ventricular myocytes. Ca2+ release after caffeine in untreated male myocytes was 377 ± 41 nM and increased to 650 ± 55 nM in isoproterenol-treated myocytes (P <0.05). Ca2+ release after caffeine addition in untreated females was 376 ± 27 nM and increased to 503 ± 49 nM with isoproterenol, significantly less than in male myocytes treated with isoproterenol (P <0.05). Treatment of female myocytes with N G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase (NOS), resulted in higher SR Ca2+ release than that measured in females treated only with isoproterenol and was not significantly different from that measured in males with isoproterenol. Female myocytes also have significantly higher levels of neuronal NOS. This gender difference in SR Ca2+ handling may contribute to reduced ischemia-reperfusion injury observed in females.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume285
Issue number6 54-6
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Sarcoplasmic Reticulum
Isoproterenol
Calcium
Muscle Cells
Caffeine
Reperfusion Injury
Myocardial Reperfusion Injury
Nitric Oxide Synthase Type I
Ethane
Fura-2
NG-Nitroarginine Methyl Ester
Nitric Oxide Synthase
Myocardial Ischemia
Rabbits
Acids

Keywords

  • Ischemia
  • Neuronal nitric oxide synthase

ASJC Scopus subject areas

  • Physiology

Cite this

Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. / Chen, Jarvis; Petranka, John; Yamamura, Ken; London, Robert E.; Steenbergen, Charles Jr; Murphy, Elizabeth.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 285, No. 6 54-6, 12.2003.

Research output: Contribution to journalArticle

Chen, Jarvis ; Petranka, John ; Yamamura, Ken ; London, Robert E. ; Steenbergen, Charles Jr ; Murphy, Elizabeth. / Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. In: American Journal of Physiology - Heart and Circulatory Physiology. 2003 ; Vol. 285, No. 6 54-6.
@article{371759f26d4d44828169f777f76b803e,
title = "Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol",
abstract = "Males exhibit enhanced myocardial ischemia-reperfusion injury versus females under hypercontractile conditions associated with increased sarcoplasmic reticulum (SR) Ca2+. We therefore examined whether there were gender differences in SR Ca2+. We used NMR Ca 2+ indicator 1,2-bis(2-amino-5,6-difluorophenoxy)-ethane-N,N,N′ ,N′-tetraacetic acid to measure SR Ca2+ in perfused rabbit hearts. Isoproterenol increased SR Ca2+ in males from a baseline of 1.13 ± 0.07 to 1.52 ± 0.24 mM (P <0.05). Female hearts had basal SR Ca2+ that was not significantly different from males (1.04 ± 0.03 mM), and addition of isoproterenol to females resulted in a time-averaged SR Ca2+ (0.97 ± 0.07 mM) that was significantly less than in males. To confirm this difference, we measured caffeine-induced release of SR Ca2+ with fura-2 in isolated ventricular myocytes. Ca2+ release after caffeine in untreated male myocytes was 377 ± 41 nM and increased to 650 ± 55 nM in isoproterenol-treated myocytes (P <0.05). Ca2+ release after caffeine addition in untreated females was 376 ± 27 nM and increased to 503 ± 49 nM with isoproterenol, significantly less than in male myocytes treated with isoproterenol (P <0.05). Treatment of female myocytes with N G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase (NOS), resulted in higher SR Ca2+ release than that measured in females treated only with isoproterenol and was not significantly different from that measured in males with isoproterenol. Female myocytes also have significantly higher levels of neuronal NOS. This gender difference in SR Ca2+ handling may contribute to reduced ischemia-reperfusion injury observed in females.",
keywords = "Ischemia, Neuronal nitric oxide synthase",
author = "Jarvis Chen and John Petranka and Ken Yamamura and London, {Robert E.} and Steenbergen, {Charles Jr} and Elizabeth Murphy",
year = "2003",
month = "12",
language = "English (US)",
volume = "285",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 54-6",

}

TY - JOUR

T1 - Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol

AU - Chen, Jarvis

AU - Petranka, John

AU - Yamamura, Ken

AU - London, Robert E.

AU - Steenbergen, Charles Jr

AU - Murphy, Elizabeth

PY - 2003/12

Y1 - 2003/12

N2 - Males exhibit enhanced myocardial ischemia-reperfusion injury versus females under hypercontractile conditions associated with increased sarcoplasmic reticulum (SR) Ca2+. We therefore examined whether there were gender differences in SR Ca2+. We used NMR Ca 2+ indicator 1,2-bis(2-amino-5,6-difluorophenoxy)-ethane-N,N,N′ ,N′-tetraacetic acid to measure SR Ca2+ in perfused rabbit hearts. Isoproterenol increased SR Ca2+ in males from a baseline of 1.13 ± 0.07 to 1.52 ± 0.24 mM (P <0.05). Female hearts had basal SR Ca2+ that was not significantly different from males (1.04 ± 0.03 mM), and addition of isoproterenol to females resulted in a time-averaged SR Ca2+ (0.97 ± 0.07 mM) that was significantly less than in males. To confirm this difference, we measured caffeine-induced release of SR Ca2+ with fura-2 in isolated ventricular myocytes. Ca2+ release after caffeine in untreated male myocytes was 377 ± 41 nM and increased to 650 ± 55 nM in isoproterenol-treated myocytes (P <0.05). Ca2+ release after caffeine addition in untreated females was 376 ± 27 nM and increased to 503 ± 49 nM with isoproterenol, significantly less than in male myocytes treated with isoproterenol (P <0.05). Treatment of female myocytes with N G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase (NOS), resulted in higher SR Ca2+ release than that measured in females treated only with isoproterenol and was not significantly different from that measured in males with isoproterenol. Female myocytes also have significantly higher levels of neuronal NOS. This gender difference in SR Ca2+ handling may contribute to reduced ischemia-reperfusion injury observed in females.

AB - Males exhibit enhanced myocardial ischemia-reperfusion injury versus females under hypercontractile conditions associated with increased sarcoplasmic reticulum (SR) Ca2+. We therefore examined whether there were gender differences in SR Ca2+. We used NMR Ca 2+ indicator 1,2-bis(2-amino-5,6-difluorophenoxy)-ethane-N,N,N′ ,N′-tetraacetic acid to measure SR Ca2+ in perfused rabbit hearts. Isoproterenol increased SR Ca2+ in males from a baseline of 1.13 ± 0.07 to 1.52 ± 0.24 mM (P <0.05). Female hearts had basal SR Ca2+ that was not significantly different from males (1.04 ± 0.03 mM), and addition of isoproterenol to females resulted in a time-averaged SR Ca2+ (0.97 ± 0.07 mM) that was significantly less than in males. To confirm this difference, we measured caffeine-induced release of SR Ca2+ with fura-2 in isolated ventricular myocytes. Ca2+ release after caffeine in untreated male myocytes was 377 ± 41 nM and increased to 650 ± 55 nM in isoproterenol-treated myocytes (P <0.05). Ca2+ release after caffeine addition in untreated females was 376 ± 27 nM and increased to 503 ± 49 nM with isoproterenol, significantly less than in male myocytes treated with isoproterenol (P <0.05). Treatment of female myocytes with N G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase (NOS), resulted in higher SR Ca2+ release than that measured in females treated only with isoproterenol and was not significantly different from that measured in males with isoproterenol. Female myocytes also have significantly higher levels of neuronal NOS. This gender difference in SR Ca2+ handling may contribute to reduced ischemia-reperfusion injury observed in females.

KW - Ischemia

KW - Neuronal nitric oxide synthase

UR - http://www.scopus.com/inward/record.url?scp=0344440784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344440784&partnerID=8YFLogxK

M3 - Article

VL - 285

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6 54-6

ER -